The Discounted Cash Flow (DCF) valuation of Harpoon Therapeutics Inc (HARP) is (260.49) USD. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on DCF is -1232.1%.
Based on the latest price of 23.01 USD and our DCF valuation, Harpoon Therapeutics Inc (HARP) is a sell. selling HARP stocks now will result in a potential gain of 1232.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.2% | 5.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,626.04) - (145.24) | (260.49) |
| Upside | -7166.7% - -731.2% | -1232.1% |